Since the 1950s, anticoagulant rodenticides are used to control rodents in public health and agriculture sectors. The extensive use of these compounds has acted as selective force to rodents, leading to resistance. Resistance mechanisms have been identified in rats and mice, including the modification of the enzyme that activates vitamin K, vitamin K epoxide reductase (VKOR). Susceptibility levels of the Norway rat, Rattus norvegicus and the roof rat, Rattus rattus to coumatetralyl (first generation anticoagulant) and broamdiolone (second generation anticoagulant) by bioassay detection method under laboratory conditions were studied. Animals were trapped from Greater Cairo, Egypt in which the anticoagulant rodenticides were used to control rodents for long periods. Complete mortality was recorded for both species and sexes within the standard feeding periods (under no-choice feeding test for 6-days to coumatetralyl and 4-days to bromadiolone). Rat species under studied still susceptible to coumatetralyl and bromadiolone. The present work revealed a significant correlation between species in comparison with consumed dose and death time. R. rattus showed more active ingredient intake (mg/kg) than R. norvegicus. Death time (days), R. rattus recorded higher mean values than R. norvegicus, also females showed higher mean values compared to males.
Introduction
Rodents are very common in many Egyptian Governorates (Shoukry et al, 1986; Morsy et al, 1988) . Besides their economic hazard causing damage to agriculture and contamination of stored food materials, they also play an important role as reservoir host for many zoonotic diseases as plague and murine typhus (Abdon and Samaan, 1962; El Bahnasawy et al, 2012; Butler, 2013) , leishmaniasis El-Kady et al, 1998) , toxoplasmosis (Saleh et al, 2016) and trichinosis (Morsy et al, 2000) . They act as reservoir host for hymenolepiasis, giardiasis, amoebiasis and schistosomiasis (Morsy et al, 1981; El-Nahal et al, 1982) . The limitations of the acute rodenticides had made it virtually impossible to achieve 100% clearance of rodent populations and repeated applications of acute rodenticides to rapidly recovering. The chronic anticoagulant rodenticide revolutionized rodent control and for the first time complete control of target rodent populations was possible and practical. They inhibit vitamin K regeneration by the vitamin K Epoxide Reductase (VKOR) and cause a fatal hemorrhagic syndrome. Because of repeated use, some populations of commensal rodents have expressed resistance to these compounds (Vein et al, 2011) . First population of warfarin-resistant to Rattus norvegicus was discovered in Scotland 1958 (Boyle, 1960 and in Denmark and UK (Lund, 1964; Greaves et al, 1973) . Resistance to Rattus rattus was in Australia and Malaysia (Saunders, 1978; Lam et al, 1982) and Mus musculus in Sweden, Finland and Canada (Morgan and Petras, 1979; Mül-ler et al, 2014) . In Egypt, the continuous use of anticoagulant rodenticides to control rodents in public and agriculture sectors was the main reason selected individuals with resistance genes.
This work aimed to determine the suscept-ibility level of coumatetralyl and bromadiolone anticoagulant rodenticides used in public health to control the dominant rodent species in Great Cairo, Egypt.
Materials and Methods
Wire box traps were deodorized by cleaning with hot water and soap before used. Traps were baited, distributed in selected houses at sunset at Greater Cairo, Egypt. Traps collected next morning and transported to the laboratory (Rifaat et al, 1969) .
Rats were kept for two weeks before being tested and during this period they were caged individually and given water and a suitable diet. Two days before testing, animal's weight and sex were determined. Immature ones (less than 150gm. For the R. norvegicus & 100gm. for R. rattus), pregnant females and unhealthy rats were excluded from the experiment (WHO, 1970) . The studies were done from February to September 2016. The susceptibility levels of R. norvegicus and R. rattus (20 rodents for each level) was carried out by bioassay detection method under laboratory conditions (WHO, 1982) . Coumatetralyl 0.0375% "4-hydroxy-3-(1, 2, 3,4-tetrahydro-1-naphthyl) coumarin" was used for 6-days by no-choice feeding test. Bromadiolone 0.005% anti-coagulantrod-endicide"3-[3-(4-bromobiphenyl 4-yl)-3-hy-droxy1-phenylpropyl]-4-hydroxycoumarin" was used for 4-days by nochoice feeding test. The amount of anticoagulant bait eaten was recorded daily and food pots were replenished each day with fresh poison bait. After the completion of feeding, animals were fed on normal laboratory diet.
The death's day was recorded. The resistant rats were those survived for 24 days after six-feeding days for coumatetralyl and four-days feeding for Bromadiolone at the normal concentration.
Statistical analysis: Data were subjected to analysis for variance and the method of least significant differences (L.S.D.), the method of Duncan (1955) 
Discussion
The present study showed that coumatetralyl 0.0375% in diet (under no choice feeding test for 6 days) and bromadiolone 0.005% in diet (under no choice feeding test for 4 days) caused complete mortality (100%) of both species and two sexes of R. norvegicus and R. rattus trapped from Greater Cairo, by bioassay rechnique under laboratory condition. Results indicate that the two rat species still susceptible to coumatetralyl and bromadiolone anticoagulant rodenticides. Data revealed a significant correlation between species in comparison with consumed dose. R. rattus showed more active ingredient intake (mg/kg) than R. norvegicus. The mean intake values of coumatetralyl being 80.2 & 72.6 mg/kg to R. rattus and being 55.6 & 50.9 mg/kg to R. norvegicus for males and females, respectively. While the mean intake values of bromadiolone being 15.0 & 10.8mg/kg to R. rattus and being 9.7 & 10.9mg/kg to R. norvegicus for males and females, respectively. Time to death was taken as a parameter for anticoagulant efficacy on treated rats. In this respect, R. rattus recorded higher mean values than R. norvegicus which being 8.9 & 9.4 days for R. rattus and 5.0 & 5.1 days for R. norvegicus to coumatetralyl for males and females, respectively. While the same values recorded 7.8 & 9.0 days for R. rattus and 6.7 & 7.0 days for R. norvegicus to bromadiolone for males and females, respectively. The same correlation showed that females recorded higher mean values comparison to males. Such findings agreed to a great extent with other Egyptian studies. Zidan et al. (1997) showed that R. rattus and R. norvegicus from Qualyobia Governorate were susceptible to warfarin and flocoumafen. Hussien (2001) found that R. rattus was very susceptible to chlorophacinone. Hussien (2005) reported that the higher effect of warfarin on the prothrombin time was noticed in R. norvegicus and R. rattus in Qualyobia Governorate, indicating their susceptibility to warfarin. Mikhail and Allam (2007) showed that R. norvegicus and R. rat-tus in Qualyobia Governorate were susceptible to bromadiolone, difencoum and coumatetralyl anticoagulant rodenticides. Mikhail and Abdel-Hamid (2010) reported that bromadiolone caused complete mortality as indicated by bioassay for R. norvegicus and R. rattus trapped from Giza and Qualyobia Governorates when anticoagulant rodenticides were used for long period. Saxena et al. (2008) in India showed that 0.005% bromadiolone was very effective in controlling the increasing population of R. rattus and Tatera indica in field crops. Endepols et al. (2007) reported that a new clotting response test was used to determine the susceptibility of coumatetralyl and bromadiolone for laboratory strain of Norway rat from Germany and UK (Hampshire), and wild rats trapped from farms in Walex (UK) and Westphalia (Germany). Resistance was calculated in relation to the CD strain of Norway rats. Homozygous and heterozygous animals of a strain of resistant from Westphalia were cross-resistant to coumatetralyl and bromadiolone with higher resistance factor for bromadiolone than that in both UK strains. Pelz (2007) reported that resistance of anticoagulant rodenticides in R. norvegicus was estimated to cover an area of roughly 26000 Km2 in northwest Germany. The chemical compounds involved are warfarin, coumatetralyl, bromadiolone and, to a lesser extent, difenacoum. Control failures with house mice (Mus musculus/domesticus) suggest that resistance to high potency compounds may occur. Cao et al. (2008) reported that there was no significant difference between the susceptibility of male and female of Apodemus agrarius after treatment with 0.005% bromadiolone bait at 7 different feeding days. A. agrarius was still alive after fed on bait containing 0.005% bromadiolone for 21 days in Harbin (China), and then it could be considered as being resistant. Guidobono et al. (2010) reported that application of anticoagulant rodenticides for rodent control has showed a decrease in effectiveness through time in Buenos Aires, Argentina because of the development of resistant populations and the development of aversion behavior to M. musculus. A conducted on feeding test wild animals captured in poultry farms and laboratory strain that were fed with bromadiolone bait. Three animals of the field experimental group survived the 21 days period, while for laboratory animals mortality was 100%. Control field animals which were fed without anticoagulant showed 100% survival, evidence of the presence of anticoagulant resistant M. musculus L in the study area. Vein et al. (2011) reported that in Francecomte (France), rodents have expressed resistance to anti-vitamin Ks (AVKs) rodenticides. The water vole exhibits cyclic population outbreaks. A second generation AVK, bromadiolone, has been used for the last 20 years to control vole population. The results indicate that voles from the most heavily treated area exhibit enzymatic changes in VKOR activity hence arguing for resistance AVKs. Baert et al. (2012) investigated the distribution of anticoagulant resistance in Flanders, northern Belgium. Warfarin resistant rats were found in the western and eastern rats of Flanders. The same was found for bromadiolone except in the southeastern area, where resistance was absent. They also detected difenacoum resistance in only six rats and did not observe any resistance rats in the central part of Flanders. Andru et al. (2013) reported that rodent control in oil palm plantations in Indonesia is based principally on use of anti-vitamin K (AVK), the main anticoagulant used was coumatetralyl, a first generation AVK. A conducted a comparative study in two well established oil palm plantations in Indonesia, one without chemical control in Riau and another with intensive coumatetralyl use on BangKa. In Riau rats were much more susceptible to coumatetralyl than in BangKa. Buckle (2013) reported that anticoagulant resistance was discovered in UK Norway rats (R. norvegicus Berk.) in 1958 and continued over since. The possible detrimental impact of resistance on effective rodent control was quickly recognized, and, for almost three decades, extensive research was conducted on the geographical distribution and severity of anticoagulant resistance in UK rats. At first, surveys showed resistance only to first-generation anticoagulants, such as warfarin, chlorophacinone and coumatetralyl, but, later, resistance to the more potent second-generation anticoagulants as difenacoum and bromadiolone was also discovered. Wang et al. (2014) determined the resistance of R. norvegicus to warfarin and bromadiolone in HongKou district of Shanghai and provided evidence for rodent control. Methods of a non-selective feeding trial were conducted with 0.005% warfarin and 0.005% bromadiolone baits. Application of 0.005% warfarin and 0.005% bromadiolone baits for 6-days, occurrence rate of warfarinresistant was 0% and that bromadioloneresistant was 3.7% (1/27). R. norvegicus in Hong-Kou district is still susceptible to the first generation anticoagulant, but resistant to second generation anticoagulant. Esther (2015) reported that rodents showed genetically determined resistance, so that the control fails to respond. There were numerous resistant to Norway rats and house mice in Germany. Effective management of resistant was only possible with flocoumafen, brodifacoum and difethialone. The use of the first generation active ingredients (warfarin, chlorophacinone & coumatetralyl) and bromadiolone was uneffective. Garg et al. (2015) reported that the second generation anticoagulant, bromadiolone controled rodents all over India for the last several years.
Conclusion Rattus norvegicus and Rattus rattus in Greater Cairo were still susceptible to the anticoagulant rodenticides, coumatetralyl 0.0375% and bromadiolone 0.005% by bioassay technique under laboratory conditions. Regular evaluate to determine susceptibility and/or resistance level status to anticoagulant rodenticides to rodent species in all Egyptian Governorates should be done.
